申请人:Bayer Aktiengesellschaft
公开号:US05502062A1
公开(公告)日:1996-03-26
The present invention relates to new 2-amino-4-quinolyl-1,4-dihydropyridines of the general formula (I) ##STR1## in which R.sub.1 -R.sub.4 have the meaning given in the description, to processes for their preparation and to their use in medicaments, especially in agents for the treatment of cardiac circulatory disorders.
本发明涉及一种新的2-氨基-4-喹啉基-1,4-二氢吡啶的通式(I)如下:##STR1##其中R.sub.1 - R.sub.4的含义如说明书所述,以及其制备过程和在药物中的应用,特别是在治疗心脏循环障碍的药物中的应用。